Traws Pharma (TRAW) announced the appointment of John Leaman, MD, to its board of directors as an independent director, effective October 1, 2025. In addition, Traws’ Board of Directors has eliminated the interim notation of its key executives Iain Dukes and Charles Parker, who are now CEO and CFO, respectively. John Leaman, MD is currently the CFO at Cellarity.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRAW: